Coverage & Counting Methods
Counts describe the records included in the inspected platform snapshots, not the complete pharmaceutical market.
| Measure | Count | Definition |
|---|---|---|
| Company entries | 361 | Entries in the platform catalog; parent groups and subsidiaries are not necessarily consolidated. |
| Active trial records | 5,968 | Distinct NCT identifiers in Recruiting, Active not recruiting, Not yet recruiting, or Enrolling by invitation status. Active describes included registry statuses, not guaranteed present-day activity. |
| Distinct listed patent numbers | 5,706 | Unique base patent identifiers across the covered Orange Book data, excluding pediatric-extension suffixes as separate patents. |
| Patent display rows | 7,910 | Rows across substance groups; includes repeated numbers and pediatric extensions. There are 6,271 distinct identifiers when extension suffixes are retained. |
| Substance labels | 3,589 | Union of FDA and EMA lookup keys. These are not a harmonized count of unique molecular entities, products, or approvals. |
Dates and exclusions
These totals were calculated from public datasets retrieved on October 9, 2026. The pipeline artifact reports a generation timestamp of 2026-09-26T21:46:59Z; individual company refresh dates can differ. The patent artifact reports 2026-09-27T18:48:33Z. Retrieval does not make every underlying record current.
Trial collection is limited by the company catalog and sponsor matching. Completed, terminated, withdrawn, suspended, and unknown-status studies are outside the active-status definition. Patent coverage depends on applications retained in the lookup and is incomplete; it does not include a comprehensive biologic patent inventory. The static profile pages cover a selected subset of the platform.
Download the count definitions, results, and input hashes. Statistics used elsewhere, including a résumé, should preserve these units and the as-of date.